Yuhan Corp
KRX:000100
Yuhan Corp
KRX:000100
Price:
100 400
KRW
0.9%
Market Closed
Market Cap:
₩8.1T
Relative Value
The Relative Value of one
Yuhan Corp
stock under the Base Case scenario is
73 491.44
KRW.
Compared to the current market price of 100 400 KRW,
Yuhan Corp
is
Overvalued by 27%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
73 491.44
KRW
Overvaluation 27%
Multiples Across Competitors
Competitors Multiples
Yuhan Corp Competitors
Yuhan Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Yuhan Corp
KRX:000100
|
7.4T KRW | 3.5 | 110 | 54.4 | 109.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879B USD | 13.5 | 42.6 | 28.7 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573.4B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
257.8B CHF | 4.2 | 20 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.8B GBP | 5.1 | 29.4 | 16.3 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.8B CHF | 5.3 | 21.3 | 13.2 | 17 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.7B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.9 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
